No Data
No Data
Jefferies Maintains Vera Therapeutics(VERA.US) With Buy Rating, Raises Target Price to $58
Top 3 Health Care Stocks That Could Blast Off This Quarter
Insiders At Vera Therapeutics Sold US$1.0m In Stock, Alluding To Potential Weakness
Vera Therapeutics Grants Stock Options And RSUs To Six New Employees
LifeSci Capital Maintains Vera Therapeutics(VERA.US) With Buy Rating, Maintains Target Price $70
Vera Therapeutics: Strategic Licensing and Promising Clinical Data Justify Buy Rating